about
Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and InflammationThrombin regulation of synaptic transmission and plasticity: implications for health and diseaseAnti-Inflammatory and Anti-Thrombotic Effects of the Fungal Metabolite Galiellalactone in Apolipoprotein E-Deficient MiceNew Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)Mouse models of atherosclerosis: a historical perspective and recent advances.Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility.High-intensity Interval Training Improves Mitochondrial Function and Suppresses Thrombin Generation in Platelets undergoing Hypoxic StressNovel mediators and biomarkers of thrombosis.Platelets and their chemokines in atherosclerosis-clinical applications.Expression of BMP4 in myocardium and vascular tissue of obese mice.Yindanxinnaotong, a Chinese compound medicine, synergistically attenuates atherosclerosis progressInhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental AtherosclerosisMicroparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis.Apolipoprotein polymorphism is associated with pro-thrombotic profile in non-demented dyslipidemic subjects.Acute and persistent platelet and coagulant activities in atherothrombosis.Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.Proinflammatory signaling functions of thrombin in cancer.Angiopoietin-2 mediates thrombin-induced monocyte adhesion and endothelial permeability.Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases.The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients.Association of FV G1691A Polymorphism but not A4070G With Coronary Artery Disease.Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting
P2860
Q26775993-9B6D5D62-8E44-4CA6-AB50-763B19AEDE79Q26827343-41D9ECA2-5A65-4FE5-A7A2-8FFF65B93DC7Q27304270-F608FF73-900D-4E13-9A7E-C4507BFAAE2AQ28081366-9AF44F1C-7982-4A1F-88C9-50D29F2D2672Q30238973-F5B2C00D-5846-4EF3-AB62-CF83E649EA7CQ30243926-2CB1C099-72D8-4BFE-9E2E-96B1B5F2925AQ33830008-A293E161-CA5B-4167-9AD8-8B393E4E452CQ33864040-442EC40E-01D2-427B-9266-4A3C8A083EFDQ34019069-9C87D6DE-22FC-4073-B922-A86DD454ADFDQ35078173-469B73EF-AF8B-44DA-B5D2-10C2E3AE82D7Q35869727-0B111AD7-C38C-4161-9E18-F4BD78BA6E5CQ35894640-6FF4F3ED-479E-4C34-89A3-FC4128954B05Q35968665-B8158763-4E57-485C-B6D1-FE3199B37B92Q37070957-7E4F975F-7334-494F-9F2C-39693DCC7D2CQ38543304-A6CE05E7-393E-4AB4-8792-B3992571642CQ38601647-F226B5B3-AEAC-423A-BE30-E3A5C2EFEB58Q39048394-4EBB0386-42FA-4777-A835-89CE003D8BFEQ39724484-4E466507-C4D5-4C5E-988D-ED004EEFBBF4Q42696477-B383218A-EF02-4F83-A21B-BFAA7C4835D7Q47752167-6252D58A-235B-449E-ABC0-D24740D08524Q49593658-538E4BC7-0908-45BE-A625-04FE4EB4729CQ55359034-D41B5729-A313-43B2-B1E2-DF29DBDB9531Q55652795-A06537AC-D5BD-499D-8070-342BD9F41958Q58795845-6B6B8634-F7D9-4655-8E1D-772318A3AB67
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Thrombin generation and atherosclerosis.
@en
type
label
Thrombin generation and atherosclerosis.
@en
prefLabel
Thrombin generation and atherosclerosis.
@en
P2860
P1476
Thrombin generation and atherosclerosis.
@en
P2093
Henri M H Spronk
P2860
P2888
P356
10.1007/S11239-013-1026-5
P577
2014-01-01T00:00:00Z